Research on transgenic mice expressing human superoxide dismutase 1 (SOD1) with a G93A mutation (hSOD1G93A), a well-established animal ALS model, showed that the administration of anti-inflammatory drugs prolonged the survival of these mice [57]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.